Pooled randomized phase 3 trials· 2010
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation
Falutz J|et al.
Journal of Clinical Endocrinology and Metabolism
- PubMed
- 20554713
- Evidence level
- high
- Verification
- verified
Summary
Pooled analysis of two phase 3 studies in antiretroviral-treated adults with excess abdominal fat.
Limitations
Results are indication-specific and should not be generalized to routine obesity treatment.